Giorgia Guglielmi
Oncology
Plant compounds and gut microbiota activity influence how cancer drugs work and should be considered in treatment.
Dentistry
Tracking the oral microbiota can help identify ECC risk early and inform prevention strategies in children, even before visible signs of decay.
Endocrinology, Nutrition
AceCel is a promising way to help manage obesity by targeting gut bacteria and metabolism together.
Oncology, Gastroenterology
Nanoparticle-based approaches are a promising strategy for treating colorectal cancer.
Gastroenterology
Fungal metabolites such as FF-C1 may offer a new therapeutic approach for treating MAFLD and related conditions.
Dermatology
Certain barriers on the skin prevent easy colonization of new strains and specific life stages, such as adolescence, may be crucial for successful probiotic interventions.
Gastroenterology, Scientific research
Even small differences between strains of gut bacteria—often within the same species—can sway how these microbes interact with the human body and influence disease outcomes.
Oncology
Genetic factors can influence tumor-associated microbes, offering insights into colorectal cancer progression and potential therapeutic targets.
Gastroenterology
TCA can help to manage IBD by supporting the gut barrier and influencing microbiota composition.
Pneumology, Pediatrics
The findings of a recent study highlight the importance of early-life gut microbes in shaping lung health and add to evidence that microbiota composition can influence asthma risk.